Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial

被引：0

作者：

Yohei Kamata

Takaomi Kessoku

Tomoko Shimizu

Takashi Kobayashi

Takeo Kurihashi

Satsuki Sato

Syotaro Kuraji

Norio Aoyama

Tomoyuki Iwasaki

Shogo Takashiba

Nobushiro Hamada

Toshiro Kodama

Toshiyuki Tamura

Satoshi Ino

Takuma Higurashi

Masataka Taguri

Takeharu Yamanaka

Masato Yoneda

Haruki Usuda

Koichiro Wada

Atsushi Nakajima

Masato Minabe

机构：

[1] Yokohama Clinic,Department of Highly Advanced Oral Stomatology

[2] Kanagawa Dental University,Department of Gastroenterology and Hepatology

[3] Yokohama City University Graduate School of Medicine,Department of Internal Medicine

[4] Yokohama Clinic,Division of Periodontology, Department of Oral Interdisciplinary Medicine, Graduate School of Dentistry

[5] Kanagawa Dental University,Department of Pathophysiology – Periodontal Science

[6] Kanagawa Dental University,Division of Microbiology, Department of Oral Science Graduate School of Dentistry

[7] Iwasaki Internal Medicine Clinic,Department of Implantology and Periodontology, Graduate School of Dentistry

[8] Okayama University Graduate School of Medicine,Division of Prosthetic Dentistry, Department of Highly Advanced Stomatology

[9] Dentistry and Pharmaceutical Sciences,Department of Biostatistics

[10] Kanagawa Dental University,Department of Pharmacology

[11] Kanagawa Dental University,undefined

[12] Graduate School of Dentistry,undefined

[13] Kanagawa Dental University,undefined

[14] Yokohama City University Graduate School of Medicine,undefined

[15] Shimane University School of Medicine,undefined

来源：

Trials | / 21卷

关键词：

NAFLD; Periodontal treatment; Lipopolysaccharides; Alanine aminotransferase; Immunoglobulin G;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial
Rafalsky, Vladimir
Averyanov, Alexander
Bart, Boris
Minina, Elena
Putilovskiy, Mikhail
Andrianova, Elena
Epstein, Oleg
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 51 : 47 - 55
[22] Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial
Kalita, J.
Misra, U. K.
Prasad, S.
Bhoi, S. K.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (08) : 2246 - 2251
[23] Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia:: a randomized, open-label, multicenter study
Rea-Neto, Alvaro
Niederman, Michael
Lobo, Suzana Margareth
Schroeder, Eric
Lee, Michael
Kaniga, Kone
Ketter, Nzeera
Prokocirner, Philippe
Friedland, Ian
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (07) : 2113 - 2126
[24] A Randomized, Open-Label, Parallel Two-Arm Study Evaluating the Efficacy of HP Acthar Injection Gel in the Treatment of Adults with Treatment Resistant Chronic Migraine
Cady, Roger
Mechtler, Laszlo
McAllister, Peter
Rothrock, John
Manley, Heather
Cady, Ryan
NEUROLOGY, 2016, 86
[25] An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
Rindra Vatosoa Randremanana
Mihaja Raberahona
Mamy Jean de Dieu Randria
Minoarisoa Rajerison
Voahangy Andrianaivoarimanana
Agathe Legrand
Tsinjo Fehizoro Rasoanaivo
Ravaka Randriamparany
Théodora Mayouya-Gamana
Reziky Mangahasimbola
Josie Bourner
Alex Salam
Annelies Gillesen
Tansy Edwards
Matthieu Schoenhals
Laurence Baril
Peter Horby
Piero Olliaro
Trials, 21
[26] EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients
D. S. Wöhl
B. James
M. Götz
F. Brennfleck
I. Holub-Hayles
I. Mutzbauer
S. Baccar
S. M. Brunner
E. K. Geissler
H. J. Schlitt
Trials, 24
[27] Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
Ryoichi Ishibashi
Yoko Takatsuna
Masaya Koshizaka
Tomoaki Tatsumi
Sho Takahashi
Kengo Nagashima
Noriko Asaumi
Miyuki Arai
Fumio Shimada
Kaori Tachibana
Yoshihiro Watanabe
Ko Ishikawa
Akiko Hoshino
Kyohei Yamamoto
Mariko Kubota-Taniai
Takafumi Mayama
Shuichi Yamamoto
Koutaro Yokote
Diabetes Therapy, 2020, 11 : 1891 - 1905
[28] Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
Ishibashi, Ryoichi
Takatsuna, Yoko
Koshizaka, Masaya
Tatsumi, Tomoaki
Takahashi, Sho
Nagashima, Kengo
Asaumi, Noriko
Arai, Miyuki
Shimada, Fumio
Tachibana, Kaori
Watanabe, Yoshihiro
Ishikawa, Ko
Hoshino, Akiko
Yamamoto, Kyohei
Kubota-Taniai, Mariko
Mayama, Takafumi
Yamamoto, Shuichi
Yokote, Koutaro
DIABETES THERAPY, 2020, 11 (08) : 1891 - 1905
[29] EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients
Woehl, D. S. A.
James, B.
Goetz, M.
Brennfleck, F.
Holub-Hayles, I.
Mutzbauer, I.
Baccar, S.
Brunner, S. M.
Geissler, E. K.
Schlitt, H. J.
TRIALS, 2023, 24 (01)
[30] Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial
Abdoul Habib Beavogui
Alioune Camara
Alexandre Delamou
Mamadou Saliou Diallo
Abdoulaye Doumbouya
Karifa Kourouma
Patrice Bouedouno
Timothée Guilavogui
Samaly dos Santos Souza
Julia Kelley
Eldin Talundzic
Aissata Fofana
Mateusz M. Plucinski
Malaria Journal, 19

← 1 2 3 4 5 →